Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP synthase mitochondrial F1 complex assembly factor 1 (ATPAF1) is a nuclear-encoded mitochondrial protein required for the assembly of the F1 catalytic portion of mitochondrial ATP synthase. ATPAF1 specifically interacts with the F1 beta subunit, preventing its nonproductive aggregation and enabling correct assembly of the ATP synthase complex. This factor is essential for proper mitochondrial ATP production but is not itself an enzyme, receptor, or transporter. Several alternatively spliced transcript variants exist; however, the biological significance of some is unclear. No evidence identifies ATPAF1 as a direct drug target, disease biomarker, or therapeutic agent[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP synthase mitochondrial F1 complex assembly factor 1 (ATPAF1).